insights_auto
Why is KAPA down 5.62%?
Dive Deeperchevron_right
KAPA:NYSEAMERICAN
Kairos Pharma Ltd
$0.45
arrow_downward
-5.62%(-0.027) 1D
$0.46
arrow_upward
+2.51% (+0.011)bedtimeAfter hours
Closed: Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KAPA...
Open
$0.50
High
$0.50
Low
$0.45
Mkt. cap
1.54M
Avg. vol.
677.84K
Volume
12.57K
52-wk high
$7.28
52-wk low
$0.42
EPS
-$1.95
Shares outstanding
3.38M
No. of employees
3
Open
$0.50
High
$0.50
Low
$0.45
Mkt. cap
1.54M
Avg. vol.
677.84K
Volume
12.57K
52-wk high
$7.28
52-wk low
$0.42
EPS
-$1.95
Shares outstanding
3.38M
No. of employees
3
News stories
From web sources and news partners
BigGo Finance
·
51 minutes ago
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
The Motley Fool
·
22 hours ago
Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years
Longbridge
·
2 days ago
[Weekly Recap] CTA Net Position Hits Extreme Low, Nasdaq…
Traders Union
·
3 hours ago
Quinten Francois: Bitcoin and Ethereum underperform S&P 500 over five years
About Kairos Pharma Ltd
CEO-
Employees3
Founded2013
HeadquartersLos Angeles, California, United States
SectorHealth Care
IndustryBiotechnology
Websitekairospharma.com